Las Vegas, NV -- (SBWIRE) -- 01/16/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Dynavax Technologies Corporation(NASDAQ:DVAX), Thompson Creek Metals Company Inc (USA)(NYSE:TC), Oi SA (ADR)(NYSE:OIBR), Cell Therapeutics Inc(NASDAQ:CTIC)
Dynavax Technologies Corporation(NASDAQ:DVAX) was a volume gainer of 5.87 million shares and the average volume of the stock remained 4.97 million shares. The stock opened the session at $1.94 and finished at the end of the day at $2.00 and the stock escalated 3.63%.The market capitalization of the stock remained 525.25 million. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
For How Long DVAX will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Thompson Creek Metals Company Inc (USA)(NYSE:TC) exchanged 5.55 million shares and the average volume remained 2.23 million shares. The stock closed the session at $2.89 with the gain of 12.02%. Thompson Creek Metals Company Inc. engages in mining, milling, processing, and marketing of molybdenum products in the United States and Canada. he company was formerly known as Blue Pearl Mining Ltd. and changed its name to Thompson Creek Metals Company Inc. in May 2007.
Will TC Continue To Move Higher? Find Out Here
Oi SA (ADR)(NYSE:OIBR) decreased -1.06% and its closing price was $1.86. The volume of the stock was 5.31 million shares and the average volume remained 5.51 million shares. The market capitalization of the stock remained 3.05 billion. The beta of the stock remained 1.32. Oi S.A., through its subsidiaries, provides integrated telecommunication services for residential customers, companies, and governmental agencies in Brazil. It operates in three segments: Fixed-Line and Data Transmission Services, Mobile Services, and Other Services.
Will OIBR Get Buyers Even After The Recent Rally? Find Out Here
Cell Therapeutics Inc(NASDAQ:CTIC) exchanged 5.18 million shares in the previous trading session, and its average trading remained 3.18 million shares. CTIC it closed the trading at $3.05. The market capitalization of the stock remained 445.87 million. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. Cell Therapeutics, Inc. was founded in 1991 and is headquartered in Seattle, Washington.
How Should Investors Trade CTIC Now? Don’t Miss out a Special Trend Analysis
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)